Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 194

    1.

    Chemotherapy in women with breast cancer.

    Harlan LC, Clegg LX, Warren JL.

    Ann Intern Med. 2003 Nov 18;139(10):868; author reply 868-9. No abstract available. PMID: 14623632 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chemotherapy in women with breast cancer.

    Liebmann J, Haskins C, McAneny B, Giudice R, Clark D, Marshall N.

    Ann Intern Med. 2003 Nov 18;139(10):867-8; author reply 868-9; discussion 869. No abstract available. PMID: 14623631 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Chemotherapy in women with breast cancer.

    [No authors listed]

    Ann Intern Med. 2003 Jan 21;138(2):I16. No abstract available. PMID: 12529113 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer.

    Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS.

    Ann Intern Med. 2003 Jan 21;138(2):90-7. Erratum in: Ann Intern Med. 2003 Nov 18;139(10):873. PMID: 12529090 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.

    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.

    J Natl Cancer Inst Monogr. 2006;(36):7-15.PMID: 17032888 [PubMed - indexed for MEDLINE]Related articles

    6.

    The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer.

    Laliberte L, Fennell ML, Papandonatos G.

    Med Care. 2005 May;43(5):471-9.PMID: 15838412 [PubMed - indexed for MEDLINE]Related articles

    7.

    Adjuvant therapy for breast cancer: current controversies and future prospects.

    Wood WC.

    J Natl Cancer Inst Monogr. 2001;(30):16. No abstract available. PMID: 11773286 [PubMed - indexed for MEDLINE]Related articles

    8.

    NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.

    [No authors listed]

    J Tenn Med Assoc. 1981 Mar;74(3):190-2. No abstract available. PMID: 7024644 [PubMed - indexed for MEDLINE]Related articles

    9.

    Use of adjuvant systemic therapy for early breast cancer among women 65 years of age and older.

    Balasubramanian BA, Gandhi SK, Demissie K, August DA, Kohler B, Osinubi OY, Rhoads GG.

    Cancer Control. 2007 Jan;14(1):63-8.PMID: 17242672 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.

    [No authors listed]

    Conn Med. 1980 Nov;44(11):721-3. No abstract available. PMID: 7226778 [PubMed - indexed for MEDLINE]Related articles

    11.

    Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.

    Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI.

    Breast Cancer Res Treat. 2006 Oct;99(3):313-21. Epub 2006 Apr 1.PMID: 16583264 [PubMed - indexed for MEDLINE]Related articles

    12.

    Audit of compliance to adjuvant chemotherapy and radiotherapy guidelines in breast cancer in a cancer network.

    Balasubramanian SP, Murrow S, Holt S, Manifold IH, Reed MW.

    Breast. 2003 Apr;12(2):136-41.PMID: 14659343 [PubMed - indexed for MEDLINE]Related articles

    13.

    Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.

    Cronin DP, Harlan LC, Potosky AL, Clegg LX, Stevens JL, Mooney MM.

    Am J Gastroenterol. 2006 Oct;101(10):2308-18.PMID: 17032196 [PubMed - indexed for MEDLINE]Related articles

    14.

    Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

    Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R.

    J Clin Oncol. 2006 Feb 20;24(6):872-7.PMID: 16484696 [PubMed - indexed for MEDLINE]Related articles

    15.

    NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.

    [No authors listed]

    N Engl J Med. 1980 Oct 2;303(14):831-2. No abstract available. PMID: 6997737 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of screening and adjuvant therapy on mortality from breast cancer.

    Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators.

    N Engl J Med. 2005 Oct 27;353(17):1784-92.PMID: 16251534 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.

    Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.

    J Clin Oncol. 2007 Jun 20;25(18):2522-7.PMID: 17577029 [PubMed - indexed for MEDLINE]Related articles

    19.

    Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information.

    Peele PB, Siminoff LA, Xu Y, Ravdin PM.

    Med Decis Making. 2005 May-Jun;25(3):301-7.PMID: 15951457 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.

    Edwards S.

    Find Brief. 2005 Jan;8(1):1-3. No abstract available. PMID: 15672527 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data